Mr. Clay is a time-tested scientist who is passionate about cancer therapies. In 1998, Clay founded the company, Seattle Genetics, with the aim of enhancing scientific innovations. Besides, he also purposed to impact the healthcare industry by introducing new drugs through rigorous research. Clay serves in the company as the president, CEO, and chairman, and is applauded for the milestones the company has made. They celebrate the creation of antibody-drug conjugates (ADCs), ADC product, as well as ADCETRIS®. In 2011, they got their ADC and ADCETRIS® products approved by FDA. So far, ADCETRIS® has been embraced across the world, with over 65 countries endorsing the brand.
Unique Traits Upheld by Clay Siegall
Clay has been in pursuit of his dream for over three decades now. It excites him to wake up every day and push for cancer treatment. As he is in his 40s, Clay cherishes interaction with smart people. While some time back he may have thought he knew enough, right now he appreciates taking time with other people possessing greater skills. In fact, in his endeavor to push ideas to fruition, he collaborates with innovators in oncology. The strategy enables them to employ new technology that keeps advancing their approach to help the cancer patients.
Mr. Clay Siegall is devoted to his course. He says that when he was 19, he watched his father fight cancer. The difficult battle opened Clay’s eyes to the loopholes in the field of oncology. Most of the necessary tools were missing, and when Clay was 24, his father passed on. He attended George Washington University for his doctorate in genetics. After that, he worked at a Pharmaceutical Research Institute, which is what triggered the idea of Seattle. He gained invaluable experience that helps him in the management of the company.
Clay’s primary objective is to see the cancer patients free. He lives a selfless life, pushing for what he believes, which is impacting other people’s lives. The Ph.D. holder is mostly known for his zeal in transforming the healthcare community. Clearly, there are all the reasons to believe in stopping the life-threatening condition.